Rhenman & Partners Asset Management’s St Jude Medical STJ Stock Holding History

Rhenman & Partners Asset Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-180,000	Closed	-$9.9M	–	100
2016 Q1	$9.9M	Buy	180,000 +5,000	+3%	+$272K	1.97%	13
2015 Q4	$10.8M	Sell	175,000 -15,000	-8%	-$946K	1.63%	26
2015 Q3	$12M	Buy	190,000 +107,000	+129%	+$7.64M	1.91%	19
2015 Q2	$6.07M	Buy	83,000 +34,200	+70%	+$2.47M	0.73%	45
2015 Q1	$3.19M	Buy	48,800 +8,800	+22%	+$585K	0.54%	63
2014 Q4	$2.6M	Sell	40,000 -17,000	-30%	-$1.09M	0.75%	54
2014 Q3	$3.43M	Buy	57,000 +17,000	+43%	+$1.11M	1%	37
2014 Q2	$2.77M	Buy	40,000 +5,606	+16%	+$363K	0.82%	43
2014 Q1	$2.25M	Sell	34,394 -5,606	-14%	-$365K	0.68%	53
2013 Q4	$2.48M	Buy	+40,000	New	+$2.32M	0.97%	46

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rhenman & Partners Asset Management's STJ Position: Q2 2016 in Review

Rhenman & Partners Asset Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 180,000 shares — an estimated $9.9M sold.

Rhenman & Partners Asset Management first reported a position in STJ in Q4 2013 and held it in 10 quarters. The position peaked at $12M in Q3 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

Rhenman & Partners Asset Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
Rhenman & Partners Asset Management sold 180,000 St Jude Medical shares in Q2 2016, an estimated $9.9M.
Rhenman & Partners Asset Management first reported a position in St Jude Medical in Q4 2013 and held it in 10 quarters.
Rhenman & Partners Asset Management's St Jude Medical position peaked at $12M in Q3 2015.
615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2016, filed 1 Aug 2016.